RACHEL QUINN: Open Payments
NPI 1962945360 · POTOMAC, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 66 payments from 21 companies in 2025. Trend: 2023 $985 · 2024 $2,213 · 2025 $1,418
Food & beverage: $1,318Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $322 |
| GENZYME CORPORATION | 4 | $142 |
| ABBVIE INC. | 5 | $127 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| PFIZER INC. | 5 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Medtronic, Inc. | 2 | $74 |
| LEO Pharma Inc. | 2 | $63 |
| Lilly USA, LLC | 3 | $62 |
| Incyte Corporation | 2 | $44 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, CIBINQO, TALTZ, Rhapsido, OPZELURA, OCTOPUS.
Industry payments across MD — which companies pay providers there.
